GLP-1 use is reshaping spending in categories far from food
17%
taken GLP-1 drugs
+23%
US perfume sales
StatTrends
17% of people have taken or are taking GLP-1 weight-loss drugs, up from 12% a year earlier, and UBS forecasts 40 million users and $126 billion in sales by 2029. Second-order effects are already visible: US perfume sales to GLP-1 users rose 23% as suppressed appetite redirects the desire for pleasure into other categories.
Source
VML, The Future 100: 2026 (2026)
VML Intelligence (Emma Chiu, Marie Stafford)
VML Intelligence SONAR; UBS; NielsenIQ · The Future 100: 2026, s. 140 and 157
Go to the originalMore from this source
StatPeople are pessimistic about the world but optimistic about their own livesStatNine in ten people want experiences that outlast the experience itselfStatPeople are openly asking brands to entertain them - and say most brands all look the sameStatGenerative AI use is mainstream, from research all the way to companionshipWarningAI adoption is mass-market but the anxiety adopted right along with itStatFour in five shoppers still prefer a human over a botStatConsumers will let AI plan the shop but not spend the moneyPrincipleThe public draws the AI-human line at empathy and creativityStatCreativity now outranks possessions as a marker of statusStatMost people don't care if an ad was made by AI - but music gets judged harderStatConsumers protect spending on children, health and pets and cut nearly everything elsePrincipleTreatonomics: consumers trade down everywhere except the small joys